多囊卵巢综合征患者血清microRNA-27a、microRNA-320的表达及其临床意义
作者:
作者单位:

1.海南西部中心医院 妇产科,海南 儋州 571799;2.海南医学院第一附属医院 生殖医学科,海南 海口 570102

中图分类号:

R711.75

基金项目:

国家自然科学基金(No:81560244)


Expression and clinical significance of miR-27a and miR-320 in patients with polycystic ovarian syndrome
Author:
Affiliation:

1.Department of Obstetrics and Gynecology, Hainan West Central Hospital, Danzhou, Hainan 571799, China;2.Department of Reproductive Medicine, The First Affiliated Hospital of Hainan Medical College, Haikou, Hainan 570102, China

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献 [25]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    目的 探讨血清microRNA-27a(miR-27a)、microRNA-320(miR-320)在多囊卵巢综合征(PCOS)患者中的表达及临床意义。方法 选取2017年1月—2020年8月海南西部中心医院收治的180例PCOS患者,根据胰岛素抵抗指数(HOMA-IR)分为IR组113例(HOMA-IR≥ 2.58)和NIR组67例(HOMA-IR< 2.58);另选取该院体检的健康女性80例作为对照组。于月经第3~5天采集静脉血,检测血清miR-27a、miR-320的表达,以及性激素、糖脂代谢、胰岛素抵抗指标。经阴道超声测量卵巢体积并计数卵泡数。分析miR-27a、miR-320表达与BMI、性激素、糖脂代谢、胰岛素抵抗、卵巢体积、卵泡数的相关性及PCOS发病的影响因素。结果 IR组BMI、血清睾酮(T)、总胆固醇(TC)、胰岛素抵抗(HOMA-IR)、miR-27a mRNA的相对表达量高于NIR组和对照组(P <0.05),miR-320 mRNA的相对表达量低于NIR组和对照组(P <0.05)。NIR组BMI、血清T、TC、HOMA-IR、miR-27a mRNA的相对表达量高于对照组(P <0.05),miR-320 mRNA的相对表达量低于对照组(P <0.05)。血清miR-27a的表达与BMI、卵泡数、卵巢体积、T、TC、HOMA-IR呈正相关(r =0.749、0.835、0.764、0.867、0.907和0.882,均P <0.05),血清miR-320表达与卵泡数、卵巢体积、T、HOMA-IR呈负相关(r =-0.791、-0.808、-0.768和-0.752,均P <0.05)。卵泡数增加[R=1.865(95%CI:1.252,2.776)]、T水平升高[R=1.536(95% CI:1.179,2.001)]、HOMA-IR增加[R=1.702(95% CI:1.185,2.446)]、miR-27a高表达[R=1.933(95% CI:1.278,2.923)]、miR-320低表达[R=0.610(95% CI:0.467,0.796)]是PCOS易感因素(P <0.05)。联合miR-27a、miR-320诊断PCOS的AUC为0.917(95% CI:0.869,0.964),高于单独诊断的0.708(95% CI:0.637,0.779)和0.676(95% CI:0.602,0.750)。结论 PCOS患者血清miR-27a表达上调,miR-320表达下调,miR-27a高表达、miR-320低表达与PCOS易感和胰岛素抵抗有关,可作为PCOS诊断指标。

    Abstract:

    Objective To investigate the expression and clinical significance of miR-27a and miR-320 in patients with polycystic ovarian syndrome (PCOS).Method A total of 180 cases of PCOS patients admitted to Hainan West Central Hospital from January 2017 to August 2020 were selected and divided into IR group (HOMA-IR≥ 2.58, 113 cases) and NIR group (HOMA-IR < 2.58, 67 cases) according to insulin resistance index (HOMA-IR). Another 80 healthy women were selected as the control group. Venous blood was collected on the 3rd to 5th day of menstruation (no date for amenorrhea) to detect the expression of serum miR-27a and miR-320, sex hormone, glucose and lipid metabolism, and insulin resistance indexes. Ovarian volume and number of follicles were measured by transvaginal ultrasound. The correlation of miR-27a and miR-320 expression with BMI, sex hormone, glucose and lipid metabolism, insulin resistance, ovarian volume, follicle number, and pathogenesis factors of PCOS were analyzed.Results The levels of BMI, serum testosterone (T), total cholesterol (TC), insulin resistance (HOMA-IR), and miR-27a in IR groups were higher than those in NIR group and control group (P < 0.05), and the expression of miR-320 was lower than that in NIR group and control group (P < 0.05). The levels of BMI, serum T, TC, HOMA-IR, and miR-27a in NIR group were higher than those in control group (P < 0.05), and the expression of miR-320 was lower than that in control group (P < 0.05). Serum miR-27a expression was positively correlated with BMI (r = 0.749), follicle number (r = 0.835), ovarian volume (r = 0.764), T (r = 0.867), TC (r = 0.907) and HOMA-IR (r = 0.882) (all P < 0.05), and miR-320 was negatively correlated with follicle number (r = -0.791), ovarian volume (r = -0.808) , T (r = -0.768) and HOMA-IR (r = -0.752) (all P < 0.05). Higher follicle number [R= 1.865, (95% CI: 1.252, 2.776)], increased T level [O^R=1.536, (95% CI: 1.179, 2.001)], increased HOMA-IR [R= 1.702 (95% CI: 1.185, 2.446)], high expression of miR-27a [R= 1.933, (95% CI: 1.278, 2.923)], and low expression of miR-320 [R = 0.610, (95% CI: 0.467, 0.796)] were the susceptibility factors of PCOS (P < 0.05). The AUC of combined method was 0.917, which was higher than that of alone method (P < 0.05).Conclusion The expression of miR-27a was up-regulated and miR-320 was down-regulated in PCOS patients. The high expression of miR-27a and low expression of miR-320 were related to PCOS susceptibility and insulin resistance. MiR-27a and miR-320 can be used as a diagnostic index of PCOS.

    表 3 血清miR-27a、miR-320表达与PCOS患者临床病理特征的相关性Table 3
    表 1 IR组、NIR组和对照组临床和实验室指标的比较Table 1
    表 4 PCOS影响因素的多因素Logistic回归分析相关参数Table 4
    表 2 3组血清miR-27a、miR-320 mRNA相对表达量比较Table 2
    图1 miR-27a、miR-320单独和联合诊断PCOS的ROC曲线Fig.1
    参考文献
    [1] 徐芳, 侯丽辉, 刘颖华, 等. 不同证型多囊卵巢综合征患者的临床和生化特征研究[J]. 现代生物医学进展, 2018, 18(8): 1527-1531.
    [2] TOKMAK A, KOKANALI M K, GUZEL A I, et al. Polycystic ovary syndrome and risk of endometrial cancer: a mini-review[J]. Asian Pac J Cancer Prev, 2014, 15(17): 7011-7014.
    [3] 肖华, 应小燕, 许波群. 微小RNAs与多囊卵巢综合征发病机制的研究进展[J]. 国际生殖健康/计划生育杂志, 2017, 36(1): 66-69.
    [4] WANG M M, LIU M, SUN J, et al. MicroRNA-27a-3p affects estradiol and androgen imbalance by targeting Creb1 in the granulosa cells in mouse polycytic ovary syndrome model[J]. Reprod Biol, 2017, 17(4): 295.
    [5] YU Y, DU H, WEI S, et al. Adipocyte-derived exosomal miR-27a induces insulin resistance in skeletal muscle through repression of PPARγ[J]. Theranostics, 2018, 8(8): 2171-2188.
    [6] 刘凯鲁, 胡梦婷, 蔡令波, 等. 多囊卵巢综合征患者卵泡液中6种miRNAs表达的检测[J]. 国际生殖健康/计划生育杂志, 2018, 37(1): 5-10.
    [7] 杨意. miRNA-320通过PI3K/AKT信号通路调控多囊卵巢综合征大鼠胰岛素抵抗的实验研究[D]. 武汉: 武汉大学, 2018.
    [8] ESHRE/ASRM. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J].Hum Reprod, 2004, 19(1): 41-47.
    [9] 薛艳军, 谢华, 孙美灵, 等. PCOS合并胰岛素抵抗的血脂代谢异常特点分析[J]. 中国现代医学杂志, 2014, 24(25): 94-98.
    [10] BEDNARSKA S, SIEJKA A. The pathogenesis and treatment of polycystic ovary syndrome: what's new[J]. Adv Clin Exp Med, 2017, 26(2): 359-367.
    [11] POLAK K, CZYZYK A, SIMONCINI T, et al. New markers of insulin resistance in polycystic ovary syndrome[J]. J Endocrinol Invest, 2017, 40(1): 1-8.
    [12] TENG Y L, LIN S Y, YANG H Y, et al. Effect of microRNA-409 on the pathogenesis of polycystic ovary syndrome[J]. Eur Rev Med Pharmacol Sci, 2019, 23(5): 1874-1881.
    [13] WANG Y, WANG D, JIN Z. miR-27a suppresses TLR4-induced renal ischemia-reperfusion injury[J]. Mol Med Rep, 2019, 20(2): 967-976.
    [14] CUI Q. Significance of miR-27a and miR-31 in early diagnosis and prognosis of colorectal cancer[J]. Oncol Lett, 2019, 18(3): 3092-3096.
    [15] NIE M Y, YU S, PENG S, et al. miR-23a and miR-27a promote human granulosa cell apoptosis by targeting SMAD5[J]. Biol Reprod, 2015, 93(4): 98.
    [16] KIM S Y, KIM A Y, LEE H W, et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression[J]. Biochem Biophys Res Commun, 2010, 392(3): 323-328.
    [17] ZHOU T, MENG X H, CHE H, et al. Regulation of insulin resistance by multiple miRNAs via targeting the GLUT4 signalling pathway[J]. Cell Physiol Biochem, 2016, 38(5): 2063-2078.
    [18] 余俊, 李晓兰, 张青冬.上皮性卵巢癌组织miR-320a表达对SKOV3细胞增殖和侵袭性影响[J]. 中华肿瘤防治杂志, 2019, 26(14): 1026-1030.
    [19] LI H P, FAN J H, ZHAO Y R, et al. Nuclear miR-320 mediates diabetes-induced cardiac dysfunction by activating transcription of fatty acid metabolic genes to cause lipotoxicity in the heart[J]. Circ Res, 2019, 125(12): 1106-1120.
    [20] ZHANG Z Q, ZHANG J K, LI J M, et al. miR-320/ELF3 axis inhibits the progression of breast cancer via the PI3K/AKT pathway[J]. Oncol Lett, 2020, 19(4): 3239-3248.
    [21] CIRILLO F, CATELLANI C, LAZZERONI P, et al. miRNAs regulating insulin sensitivity are dysregulated in polycystic ovary syndrome (PCOS) ovaries and are associated with markers of inflammation and insulin sensitivity[J]. Front Endocrinol (Lausanne), 2019, 10: 879.
    [22] YIN M M, WANG X R, YAO G D, et al. Transactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteins[J]. J Biol Chem, 2014, 289(26): 18239-18257.
    [23] QIN X Q, LIVINGSTON D M, KAELIN W G, et al.Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis[J]. Proc Natl Acad Sci USA, 1994, 91(23): 10918-10922.
    [24] NO?L J C, BORGHESE B, VAIMAN D, et al. Steroidogenic factor-1 expression in ovarian endometriosis[J]. Appl Immunohistochem Mol Morphol, 2010, 18(3): 258-261.
    [25] LING H Y, OU H S, FENG S D, et al. Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes[J]. Clin Exp Pharmacol Physiol, 2009, 36(9): e32-e39.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

刘萍,李玮,谢宝国,于春玲.多囊卵巢综合征患者血清microRNA-27a、microRNA-320的表达及其临床意义[J].中国现代医学杂志,2021,(15):19-25

复制
分享
文章指标
  • 点击次数:51
  • 下载次数: 173
  • HTML阅读次数: 19
  • 引用次数: 0
历史
  • 收稿日期:2021-04-07
  • 在线发布日期: 2023-10-31
文章二维码